# TOBRAMYCIN
> **ANDA210871** · Abbreviated New Drug Application (Generic) · Sponsor: LUOXIN AUROVITAS · Approved 2021-01-22
## Drug
- **FDA Application Number:** ANDA210871
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOBRAMYCIN
- **Generic name:** TOBRAMYCIN
- **Active ingredients:** TOBRAMYCIN
- **Dosage form:** SOLUTION
- **Route:** INHALATION
- **Marketing status:** Discontinued
- **Sponsor:** LUOXIN AUROVITAS
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2021-01-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210871)
---
*MORVS · CC0 1.0*